Scientis is an emerging Swiss biotech company dedicated to skin pigmentation. We strive at discovering, developing and bringing to patients & consumers novel biotech treatments for skin pigmentation conditions.
Our lead compound, cysteamine is the novel biological depigmenting treatment that is safe and effective addressing the needs of dermatologists & medical aestheticians. Our pipeline includes new depigmenting active agents targeted to the medical aesthetics & beauty markets.
Dr Behrooz Kasraee is dermatologist and thought-leader in pigment cell research. Our research group is the originator of novel skin depigmenting treatments: cysteamine, methimazole, ebselen and pyridines and novel procedures. Beyond pigment cell researches, he leads the Swiss Vitiligo Center and the Cornavin Dermatology Clinics, Switzerland.
Descubra IMCAS Academy
Precisa de ajuda?
English
Español
Français
Português
Русский
简体中文